{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:43:53Z","timestamp":1793094233968,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.ijcard.2015.05.185","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T12:38:49Z","timestamp":1433594329000},"page":"115-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"special_numbering":"C","title":["Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy"],"prefix":"10.1016","volume":"196","author":[{"given":"Anselm A.","family":"Derda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Thum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan M.","family":"Lorenzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Bavendiek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Heineke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Keyser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Stuhrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond C.","family":"Givens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Kennel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Christian Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian D.","family":"Widder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Bauersachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Thum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9862","key":"10.1016\/j.ijcard.2015.05.185_bb0005","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","article-title":"Hypertrophic cardiomyopathy","volume":"381","author":"Maron","year":"2013","journal-title":"Lancet"},{"issue":"39","key":"10.1016\/j.ijcard.2015.05.185_bb0010","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Authors\/Task Force members","year":"2014","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.ijcard.2015.05.185_bb0015","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1111\/jcmm.12380","article-title":"MiR-451 is decreased in hypertrophic cardiomyopathy and regulates autophagy by targeting TSC1","volume":"18","author":"Song","year":"2014","journal-title":"J. Cell. Mol. Med."},{"issue":"9","key":"10.1016\/j.ijcard.2015.05.185_bb0020","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jacc.2013.09.041","article-title":"Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy","volume":"63","author":"Roncarati","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7224","key":"10.1016\/j.ijcard.2015.05.185_bb0025","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ijcard.2015.05.185_bb0030","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nm1582","article-title":"MicroRNA-133 controls cardiac hypertrophy","volume":"13","author":"Care","year":"2007","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.ijcard.2015.05.185_bb0035","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrd3864","article-title":"MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles","volume":"11","author":"van Rooij","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.ijcard.2015.05.185_bb0040","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrcardio.2014.125","article-title":"Noncoding RNAs and myocardial fibrosis","volume":"11","author":"Thum","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"issue":"15","key":"10.1016\/j.ijcard.2015.05.185_bb0045","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/eurheartj\/eht392","article-title":"A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction","volume":"35","author":"Jaguszewski","year":"2014","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcard.2015.05.185_bb0050","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.ijcard.2012.12.074","article-title":"Circulating miR-133a and miR-423-5p fail as biomarkers for left ventricular remodeling after myocardial infarction","volume":"168","author":"Bauters","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2015.05.185_bb0055","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/CIRCRESAHA.113.300226","article-title":"Non-coding RNAs in cardiac remodeling and heart failure","volume":"113","author":"Kumarswamy","year":"2013","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.ijcard.2015.05.185_bb0060","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.yjmcc.2011.07.011","article-title":"Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome","volume":"51","author":"Widera","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcard.2015.05.185_bb0065","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/eurheartj\/ehs043","article-title":"SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt\/FoxO3A-dependent pathway","volume":"33","author":"Kumarswamy","year":"2012","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.ijcard.2015.05.185_bb0070","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/mt.2014.25","article-title":"miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-beta\/Smad3 signaling","volume":"22","author":"Zhang","year":"2014","journal-title":"Mol. Ther."},{"issue":"45","key":"10.1016\/j.ijcard.2015.05.185_bb0075","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1093\/eurheartj\/ehu346","article-title":"MicroRNAs as non-invasive biomarkers of heart transplant rejection","volume":"35","author":"Duong Van Huyen","year":"2014","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ijcard.2015.05.185_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2012.12.009","article-title":"Regulation of the MIR155 host gene in physiological and pathological processes","volume":"532","author":"Elton","year":"2013","journal-title":"Gene"},{"issue":"10","key":"10.1016\/j.ijcard.2015.05.185_bb0085","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1161\/CIRCRESAHA.114.303784","article-title":"Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy","volume":"114","author":"Seok","year":"2014","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.ijcard.2015.05.185_bb0090","doi-asserted-by":"crossref","first-page":"e107556","DOI":"10.1371\/journal.pone.0107556","article-title":"Myocardial Fibrosis Induced by Exposure to Subclinical Lipopolysaccharide Is Associated with Decreased miR-29c and Enhanced NOX2 Expression in Mice","volume":"9","author":"Lew","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ijcard.2015.05.185_bb0095","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4161\/epi.6.3.14056","article-title":"Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma","volume":"6","author":"Nguyen","year":"2011","journal-title":"Epigenetics"},{"issue":"11","key":"10.1016\/j.ijcard.2015.05.185_bb0100","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1373\/clinchem.2011.168005","article-title":"Profile of microRNAs differentially produced in hearts from patients with hypertrophic cardiomyopathy and sarcomeric mutations","volume":"57","author":"Palacin","year":"2011","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ijcard.2015.05.185_bb0105","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jchromb.2014.03.027","article-title":"Analytical approaches in microRNA therapeutics","volume":"964","author":"Batkai","year":"2014","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315012917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315012917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T22:21:57Z","timestamp":1537568517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527315012917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":21,"alternative-id":["S0167527315012917"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.05.185","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.05.185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}